The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma

被引:27
|
作者
Modarres-Gilani, Mitra [1 ,2 ]
Vaezi, Maryam [1 ]
Shariat, Mamak [3 ]
Zamani, Narges [4 ]
Nourizadeh, Roghaiyeh [5 ]
机构
[1] Tabriz Univ Med Sci, Gynecol Oncol, Tabriz, Iran
[2] Univ Tehran Med Sci, Gynecol Oncol, Tehran, Iran
[3] Univ Tehran Med Sci, Maternal Fetal & Neonatal Res, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Obstet & Gynecol, Tehran, Iran
[5] Tabriz Univ Med Sci, Reprod Hlth Nursing & Midwifery Fac, Tabriz, Iran
关键词
CA125; endometrial cancer; cut-off value; LYMPH-NODE METASTASIS; CA; 125; LEVEL; CA-125; LEVELS; CANCER INCIDENCE; USEFUL MARKER; PREDICTION; MANAGEMENT; SURVIVAL; TRENDS; RISK;
D O I
10.3233/CBM-160529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Lifetime risk of developing endometrial cancer is 2.17%. There is controversy regarding the predictive value of Cancer Antigen 125 (CA125) in endometrial cancer as well as the significance of its relationship with prognostic factors and appropriate cut-off value. OBJECTIVE: The aim of the present study was to investigate the prognostic role of CA125 in advanced endometrial carcinoma and determination of the appropriate cut-off value. METHODS: A sample of 91 patients was retrospectively selected from a population of 501 patients suffering from endometrial cancer during 1995 to 2015 in accordance with the inclusion criteria. The relation between clinicopathological variables and CA125 were analyzed. In order to determine sensitivity and specificity of various cut-off levels, receiver operating characteristic (ROC) curve analysis was performed for associated factors confirmed by logistic regression analysis. RESULTS: In 35% of patients, CA125 values were 35 u/ml, and in 52%, the values were equal to or greater than 20 u/ml. High preoperative CA125 was significantly related with advanced stage, ovarian involvement, omental metastasis, and myometrial invasion equal to or greater than 50%. According to the ROC curve, the suitable cut-off value for CA125 in advanced stage (sensitivity = 73%, specificity = 55%, positive predictive value = 18%, negative predictive value = 78%) and myometrial invasion equal to or greater than 50% (sensitivity = 64%, specificity = 61%, positive predictive value = 47%, negative predictive value = 74%) was 20 u/ml. Further, the suitable cut-off value for CA125 in involvement of the ovaries (sensitivity = 77%, specificity = 72%, positive predictive value = 31%, negative predictive value = 95%) and omental involvement (sensitivity = 70%, specificity = 70%, positive predictive value = 22%, negative predictive value = 95%) was 35 u/ml. CONCLUSIONS: In endometrial carcinoma, due to the relationship of CA125 with numerous prognostic factors, it is recommended that CA125 measurement be included in preoperative evaluation. In case of high CA125 levels, complete surgical staging including lymphadenectomy and omentectomy should be considered.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 50 条
  • [1] The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma
    Nikolaou, Marinos
    Kourea, Helen P.
    Tzelepi, Vasiliki
    Adonakis, Georgios
    Scopa, Chrisoula D.
    Tsapanos, Vasilios
    Kardamakis, Dimitrios
    Kalofonos, Charalambos
    Decavalas, Georgios
    JOURNAL OF BUON, 2014, 19 (01): : 198 - 202
  • [2] Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer
    Myriokefalitaki, Eva
    Vorgias, George
    Vlahos, George
    Rodolakis, Alexandros
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (03) : 647 - 654
  • [3] Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer
    Kotowicz, Beata
    Fuksiewicz, Malgorzata
    Jonska-Gmyrek, Joanna
    Wagrodzki, Michal
    Kowalska, Maria
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 215 : 141 - 147
  • [4] Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
    Jiang, Tao
    Huang, Ling
    Zhang, Shulan
    BMC CANCER, 2015, 15
  • [5] Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma
    Gupta, Divya
    Gunter, Marc J.
    Yang, Kathleen
    Lee, Stephen
    Zuckerwise, Lisa
    Chen, Lee-may
    Goldberg, Gary L.
    Huang, Gloria S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (03) : 529 - 534
  • [6] HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
    Antonsen, Sofie L.
    Hogdall, Estrid
    Christensen, Ib J.
    Lydolph, Magnus
    Tabor, Ann
    Jakobsen, Annika Loft
    Fago-Olsen, Carsten L.
    Andersen, Erik S.
    Jochumsen, Kirsten
    Hogdall, Claus
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (11) : 1313 - 1322
  • [7] Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma
    Yildiz, Askin
    Yetimalar, Hakan
    Kasap, Burcu
    Aydin, Cetin
    Tatar, Sumeyra
    Soylu, Ferit
    Yildiz, Fatma Sebnem
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 164 (02) : 191 - 195
  • [8] Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients
    Li, Xuan
    Dai, Danian
    Chen, Bo
    He, Sirong
    Zhang, Jie
    Wen, Chunjie
    Wang, Bin
    ONCOTARGETS AND THERAPY, 2019, 12 : 8789 - 8800
  • [9] Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer
    Eva Myriokefalitaki
    George Vorgias
    George Vlahos
    Alexandros Rodolakis
    Archives of Gynecology and Obstetrics, 2015, 292 : 647 - 654
  • [10] The Prognostic Value of Preoperative Serum CA125 in Endometrioid Endometrial Cancer with Cervical Stromal and Parametrial Invasion
    Ashrafganjoei, Tahereh
    Bahman, Atieh
    Hosseini, Maryam Sadat
    Arab, Maliheh
    Farzaneh, Farah
    Moridi, Atefeh
    Faghih, Nafiseh
    Sohrabi, Somayeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (10) : 1 - 7